Extraordinary potentiation of isoproterenol cardiotoxicity by corticoid pretreatment.
D000085:Acetates; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001794:Blood Pressure; D002339:Carotid Arteries; D003692:Delayed-Action Preparations; D003900:Desoxycorticosterone / Q000008:administration & dosage / Q000494:pharmacology*; D004357:Drug Synergism; D004562:Electrocardiography; D004837:Epinephrine / Q000633:toxicity; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006854:Hydrocortisone / Q000494:pharmacology; D007279:Injections, Subcutaneous; D007545:Isoproterenol / Q000008:administration & dosage / Q000633:toxicity*; D008297:Male; D051381:Rats; D012965:Sodium Chloride; D014043:Tolazoline / Q000494:pharmacology; D014159:Transducers; D014693:Ventricular Fibrillation / Q000139:chemically induced
D000085:Acetates; D003692:Delayed-Action Preparations; D003900:Desoxycorticosterone; D012965:Sodium Chloride; D014043:Tolazoline; D007545:Isoproterenol; D006854:Hydrocortisone; D004837:Epinephrine